Durable Clinical Response to Pyrotinib After Resistance to Prior Anti-HER2 Therapy for HER2-Positive Advanced Gastric Cancer: A Case Report

Frontiers in Oncology ◽

10.3389/fonc.2019.01453 ◽

2019 ◽

Vol 9 ◽

Cited By ~ 4

Author(s):

Le-Tian Huang ◽

Jie-Tao Ma ◽

Shu-Ling Zhang ◽

Xiao-Han Li ◽

Li Sun ◽

...

Keyword(s):

Gastric Cancer ◽

Case Report ◽

Clinical Response ◽

Advanced Gastric Cancer ◽

Her2 Positive

Get full-text (via PubEx)

Sustained Clinical Benefit of Pyrotinib Combined with Capecitabine Rescue Therapy After Trastuzumab Resistance in HER2-Positive Advanced Gastric Cancer: A Case Report

OncoTargets and Therapy ◽

10.2147/ott.s310421 ◽

2021 ◽

Vol Volume 14 ◽

pp. 3983-3989

Author(s):

Xin Li ◽

Xiaoqiang Gu ◽

Jiahua Xu ◽

Ling Chen ◽

Hongwei Li ◽

...

Keyword(s):

Gastric Cancer ◽

Case Report ◽

Advanced Gastric Cancer ◽

Clinical Benefit ◽

Rescue Therapy ◽

Trastuzumab Resistance ◽

Her2 Positive

Get full-text (via PubEx)

P44-4 A case report of four patients received ramucirumab monotherapy as second-line treatment for advanced gastric cancer

Annals of Oncology ◽

10.1016/j.annonc.2021.05.761 ◽

2021 ◽

Vol 32 ◽

pp. S353

Author(s):

Kei Onodera ◽

Akiko Ichiyanagi ◽

Akari Ueno ◽

Motohiro Tani ◽

Shuji Sato ◽

...

Keyword(s):

Gastric Cancer ◽

Case Report ◽

Advanced Gastric Cancer ◽

Line Treatment ◽

Second Line

Get full-text (via PubEx)

MO5-3 Nivolumab monotherapy in 3rd-line treatment for HER2 positive or negative advanced gastric cancer

Annals of Oncology ◽

10.1016/j.annonc.2021.05.573 ◽

2021 ◽

Vol 32 ◽

pp. S298

Author(s):

Yosuke Kito

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

Line Treatment ◽

Her2 Positive

Get full-text (via PubEx)

Clinical complete response after nivolumab administered as a third-line treatment for unresectable advanced gastric cancer with peritoneal dissemination: A case report

International Journal of Surgery Case Reports ◽

10.1016/j.ijscr.2021.106161 ◽

2021 ◽

pp. 106161

Author(s):

Toshiaki Komo ◽

Takahisa Suzuki ◽

Hirofumi Tazawa ◽

Haruki Sada ◽

Hiroshi Morimoto ◽

...

Keyword(s):

Gastric Cancer ◽

Case Report ◽

Advanced Gastric Cancer ◽

Peritoneal Dissemination ◽

Complete Response ◽

Line Treatment ◽

Clinical Complete Response ◽

Third Line ◽

Third Line Treatment

Get full-text (via PubEx)

Trastuzumab deruxtecan for the treatment of HER2-positive advanced gastric cancer: a clinical perspective

Gastric Cancer ◽

10.1007/s10120-021-01164-x ◽

2021 ◽

Author(s):

Masahiko Aoki ◽

Satoru Iwasa ◽

Narikazu Boku

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

Clinical Perspective ◽

Her2 Positive

Get full-text (via PubEx)

Low-dose capecitabine plus trastuzumab as first-line treatment in patients 75 years of age or older with HER2-positive advanced gastric cancer: a pilot study

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-015-2881-x ◽

2015 ◽

Vol 76 (6) ◽

pp. 1267-1272 ◽

Cited By ~ 3

Author(s):

Young Saing Kim ◽

Sun Jin Sym ◽

Min Young Baek ◽

Inkeun Park ◽

Junshik Hong ◽

...

Keyword(s):

Gastric Cancer ◽

Pilot Study ◽

Advanced Gastric Cancer ◽

Low Dose ◽

Line Treatment ◽

First Line ◽

Her2 Positive ◽

First Line Treatment

Get full-text (via PubEx)

A Case of HER2-positive Advanced Gastric Cancer Successfully Resected by Conversion Surgery after SOX/Trastuzumab Combination Therapy

Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) ◽

10.3919/jjsa.81.1115 ◽

2020 ◽

Vol 81 (6) ◽

pp. 1115-1119

Author(s):

Eriko HARADA ◽

Naotake FUNAMIZU ◽

Satoshi ISHIYAMA

Keyword(s):

Gastric Cancer ◽

Combination Therapy ◽

Advanced Gastric Cancer ◽

Conversion Surgery ◽

Her2 Positive

Get full-text (via PubEx)

A Case Report of FOLFOX-induced Adverse Events in a Patient with Recurrent Advanced Gastric Cancer Treated with Korean Medicine

The Journal of Internal Korean Medicine ◽

10.22246/jikm.2020.41.1.81 ◽

2020 ◽

Vol 41 (1) ◽

pp. 81-87

Author(s):

Myung-hyun Ko ◽

Jae-ho Yang ◽

Hyung-joon Jeon ◽

Chong-kwan Cho ◽

Yeon-weol Lee ◽

...

Keyword(s):

Gastric Cancer ◽

Case Report ◽

Adverse Events ◽

Advanced Gastric Cancer ◽

Korean Medicine

Get full-text (via PubEx)

Bevacizumab combined with low-dose S-1 as maintenance therapy with a long progression-free survival in an elderly patient with heavily pre-treated advanced gastric cancer: A case report

Biomedical Reports ◽

10.3892/br.2012.37 ◽

2012 ◽

Vol 1 (2) ◽

pp. 239-242 ◽

Cited By ~ 2

Author(s):

JUEMIN FANG ◽

HUI WANG ◽

QING XU

Keyword(s):

Gastric Cancer ◽

Elderly Patient ◽

Case Report ◽

Maintenance Therapy ◽

Advanced Gastric Cancer ◽

Low Dose ◽

Progression Free Survival ◽

Free Survival

Get full-text (via PubEx)

Predictive Roles of HER2 Gene Amplification and Neutrophil-to-Lymphocyte Ratio on Survival in HER2-Positive Advanced Gastric Cancer Treated With Trastuzumab-Based Chemotherapy

American Journal of Clinical Oncology ◽

10.1097/coc.0000000000000810 ◽

2021 ◽

Vol Publish Ahead of Print ◽

Author(s):

Joo-Hwan Park ◽

Ja Hyun Yeo ◽

Young Saing Kim ◽

Inkeun Park ◽

Hee Kyung Ahn ◽

...

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

Gene Amplification ◽

Neutrophil To Lymphocyte Ratio ◽

Her2 Gene ◽

Her2 Positive ◽

Lymphocyte Ratio ◽

Her2 Gene Amplification

Get full-text (via PubEx)